A

Atalanta Therapeutics

62 employees

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science

Date founded

2018

Funding rounds raised

Total raised

$110M

from 1 investors over 1 rounds

A

Atalanta Therapeutics raised $110M on January 11, 2021

Investors: F-Prime Capital Partners

FAQ